Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 248.10%28.1M | 79.66%18.56M | 158.70%597K | 888.48%8.84M | 104.97%106K | 685.28%8.07M | 92.08%10.33M | 90.19%-1.02M | -79.25%894K | -206.61%-2.13M |
| Net income from continuing operations | 77.00%-2.62M | -349.25%-1.81M | 60.01%-1.96M | 116.49%617K | 108.25%526K | 45.23%-11.39M | 82.89%-402K | 0.10%-4.89M | 103.81%285K | -5.06%-6.38M |
| Operating gains losses | -223.70%-214K | -2,376.92%-296K | -76.54%19K | ---9K | --72K | 158.25%173K | 105.20%13K | 205.19%81K | ---- | ---- |
| Depreciation and amortization | 48.57%30.56M | 35.64%7.51M | 91.67%10.24M | 15.43%6.72M | 57.42%6.09M | 96.55%20.57M | 79.84%5.54M | 87.77%5.34M | 158.55%5.82M | 69.00%3.87M |
| Asset impairment expenditure | -4.56%460K | 179.20%349K | --0 | 5,650.00%111K | --0 | 7,933.33%482K | --125K | --0 | ---2K | 2,094.44%359K |
| Remuneration paid in stock | 63.04%2.74M | 38.41%573K | 110.97%827K | 51.22%803K | 56.27%536K | -31.85%1.68M | -47.40%414K | -31.11%392K | -12.66%531K | -31.54%343K |
| Other non cashItems | 46.29%5.4M | 22.94%1.52M | 23.11%1.32M | 40.87%1.29M | 172.32%1.27M | 176.14%3.69M | 1,010.29%1.24M | 45.00%1.07M | 134.62%915K | 35.86%466K |
| Change In working capital | -15.30%-8.24M | 214.61%10.7M | -226.72%-9.85M | 89.72%-692K | -957.88%-8.39M | -231.53%-7.14M | -19.88%3.4M | 68.50%-3.02M | -178.47%-6.73M | -136.39%-793K |
| -Change in receivables | -116.72%-542K | -1,211.63%-2.26M | 2,177.03%1.69M | 344.44%2.22M | -151.62%-2.19M | 141.84%3.24M | 93.99%-172K | 103.79%74K | 45.76%-909K | 438.49%4.25M |
| -Change in prepaid assets | -415.37%-1.29M | 71.68%479K | -19.55%-483K | -206.98%-1.24M | 92.49%-47K | 227.33%410K | -67.52%279K | 18.71%-404K | 306.22%1.16M | -417.36%-626K |
| -Change in payables and accrued expense | 145.15%18.09M | 106.66%18.01M | -237.90%-2.74M | 264.39%3.73M | 13.99%-904K | -62.19%7.38M | 19.03%8.71M | 140.44%1.99M | -118.99%-2.27M | -120.36%-1.05M |
| -Change in other current assets | 100.82%3K | 188.89%8K | 77.19%-13K | 103.65%11K | -200.00%-3K | -121.85%-364K | -101.26%-9K | -122.62%-57K | -167.64%-301K | -98.83%3K |
| -Change in other current liabilities | -37.54%-24.5M | -2.35%-5.54M | -79.87%-8.3M | -22.58%-5.41M | -55.69%-5.24M | -131.71%-17.81M | -202.74%-5.41M | -87.41%-4.62M | -180.74%-4.42M | -80.73%-3.37M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 248.10%28.1M | 79.66%18.56M | 158.70%597K | 888.48%8.84M | 104.97%106K | 685.28%8.07M | 92.08%10.33M | 90.19%-1.02M | -79.25%894K | -206.61%-2.13M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -42.98%-14.29M | 28.13%-2.69M | -380.64%-4.99M | -89.56%-3.74M | 11.46%-2.87M | 24.22%-9.99M | 30.89%-3.74M | 72.26%-1.04M | 32.13%-1.97M | -187.00%-3.25M |
| Net PPE purchase and sale | -60.75%-11.6M | 29.68%-1.56M | -230.97%-4.62M | -42.79%-2.69M | -59.11%-2.73M | -78.57%-7.22M | -13.27%-2.22M | -257.27%-1.4M | 29.15%-1.89M | -459.28%-1.72M |
| Net other investing changes | 3.24%-2.69M | 25.86%-1.12M | -204.20%-372K | -1,103.45%-1.05M | 90.71%-142K | 69.65%-2.78M | 56.01%-1.52M | 107.71%357K | 64.49%-87K | -85.56%-1.53M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -42.98%-14.29M | 28.13%-2.69M | -380.64%-4.99M | -89.56%-3.74M | 11.46%-2.87M | 24.22%-9.99M | 30.89%-3.74M | 72.26%-1.04M | 32.13%-1.97M | -187.00%-3.25M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -329.40%-7.35M | -595.70%-2.59M | -334.09%-2.47M | -129.50%-1.24M | -355.41%-1.05M | -106.39%-1.71M | -191.63%-372K | -102.48%-569K | -165.52%-539K | -106.43%-231K |
| Net issuance payments of debt | -288.37%-7.05M | -567.01%-2.59M | -269.24%-2.1M | -106.22%-1.29M | -361.90%-1.07M | -107.29%-1.82M | -403.13%-388K | -102.48%-569K | -5.73%-627K | -109.67%-231K |
| Net common stock issuance | -0.61%327K | -14.89%120K | --0 | 2.13%192K | --15K | -82.43%329K | -49.28%141K | --0 | -51.79%188K | --0 |
| Cash dividends paid | -108.00%-468K | 4.00%-120K | ---200K | ---- | ---- | ---225K | ---125K | --0 | ---- | ---- |
| Net other financing activities | 30.22%-157K | --0 | ---169K | ---- | ---- | ---225K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -329.40%-7.35M | -595.70%-2.59M | -334.09%-2.47M | -129.50%-1.24M | -355.41%-1.05M | -106.39%-1.71M | -191.63%-372K | -102.48%-569K | -166.83%-539K | -106.43%-231K |
| Net cash flow | ||||||||||
| Beginning cash position | -20.55%14.04M | -7.70%7.22M | 34.80%14.08M | -15.26%10.22M | -20.55%14.04M | 223.68%17.68M | -54.78%7.82M | 23.99%10.45M | 66.93%12.06M | 223.66%17.68M |
| Current changes in cash | 277.81%6.46M | 113.54%13.28M | -161.51%-6.86M | 338.57%3.86M | 31.92%-3.82M | -129.74%-3.63M | 1,549.87%6.22M | -129.57%-2.62M | -234.95%-1.62M | -417.72%-5.61M |
| End cash Position | 46.00%20.5M | 46.00%20.5M | -7.70%7.22M | 34.80%14.08M | -15.26%10.22M | -20.55%14.04M | -20.55%14.04M | -54.78%7.82M | 23.99%10.45M | 66.93%12.06M |
| Free cash from | 1,833.41%16.49M | 109.60%16.99M | -66.67%-4.02M | 719.35%6.14M | 31.81%-2.63M | 115.74%853K | 137.28%8.11M | 74.56%-2.41M | -160.23%-992K | -283.95%-3.85M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.